Simplify Logo

Full-Time

Associate Scientist

Translational Biomarkers

Posted on 3/22/2024

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

501-1,000 employees

Develops RNAi-based therapies for gene targeting

Hardware
Biotechnology
Healthcare

Compensation Overview

$65k - $78kAnnually

+ Competitive salaries + Excellent benefit package

Mid

Madison, WI, USA

Category
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • Bachelor of Science in Biology or related field
  • 3+ years of experience in cell biology, molecular biology, immunology, pharmacology or a related field of biology
  • Experience in standard cellular and molecular biology techniques (Cell culture, ELISA, Cell-based assays, Immunofluorescence, Western blotting, Microscopy, RNA/DNA isolation, qPCR)
  • Excellent problem-solving skills in assay design, data analysis and interpretation
  • Excellent oral and written communication skills
  • Self-motivated team player with the ability to thrive in a fast-paced, multi-disciplinary, matrixed environment
Responsibilities
  • Conduct/execute in vitro, ex vivo and/or in vivo studies to facilitate drug discovery and development with some independence
  • Perform gene or protein biomarker expression analysis using various methods
  • Propose and carry out ways to optimize test methods
  • Occasionally present research findings to project teams and governance bodies and prepare study reports
  • Occasionally read relevant scientific literature and propose applicable suggestions for problem-solving
  • Perform critical experiments with adherence to prescribed specifications
  • Support team lab management activities
  • Maintain a high level of productivity and quality in the lab
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

View

Arrowhead Pharmaceuticals specializes in developing RNAi-based therapies using their TRiM platform, which leverages various RNA chemistries for tissue-specific targeting, enabling rapid and durable knockdown of disease-causing genes. The TRiM platform also utilizes ligand-mediated delivery, offering potential advantages such as simplified manufacturing, reduced costs, and improved safety.

Company Stage

IPO

Total Funding

$899.9M

Headquarters

Pasadena, California

Founded

2004

INACTIVE